erin taylor kennedy

Produced by WIRED Brand Lab with Labcorp | One of the biggest challenges for people with Alzheimer’s Disease and their caregivers is the path to a correct diagnosis. Recent advancements in biomarker technology are about to change that by measuring neurodegeneration in the brain, differentiating Alzheimer’s from other forms of neurodegenerative disorders, and even producing a diagnosis years before symptoms appear. Dr. Marcia Eisenberg, Chief Scientific Officer at Labcorp, shares the development of these technologies and their implementation, physician and Professor of Neurology Dr. Marwan Sabbagh speaks to the impact of these advancements and Jamie Haendel shares her personal experience with the disease, as daughter and caregiver to Paula Haendel, a woman diagnosed with Alzheimer’s.